Clinical Trial Update: Moxonidine for Prevention of Post-ablation AFib Recurrences [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on using moxonidine to prevent atrial fibrillation recurrences after ablation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Moxonidine (moxonidine)

Snippet

Sponsor: Spyridon Deftereos | Conditions: Atrial Fibrillation | Phase 4 | Status: COMPLETED